Libre by Abbott

Name: Libre by Abbott
Rating: 4.6 (164742 reviews)
Author: Abbott Labs

By: Abbott Labs

Continuous Glucose Monitoring

Features & Capabilities

Libre by Abbott is a CGM app that pairs with FreeStyle Libre 2 and 3 sensors to deliver continuous glucose data. It updates readings every minute and presents quick insights to help you monitor glucose trends on your mobile device.

With features like LibreAssist AI for food-impact guidance and easy access to readings, trends, and settings, Libre by Abbott supports diabetes management—though it should be used alongside professional advice and device compatibility checks.

User Growth & Download Statistics

App AI GenAI Privacy & Security Data

By:

Abbott Labs

Rating:

4.60

(164,742) 3,112 new ratings

Version:

1.3.0 Last updated: 2026-04-29

Version code:

884030225

Creation date:

2025-03-31

Compatible devices:

Size:

112.19MB

URLs:

Full description:

Source:

Apple Apps Store

Data ingested on:

2026-06-10

Compare stats and ranking:

Ranking

# 2,428 ▲ 28

Other rankings

#15 in diabetes keyword 1 ▲ 1

Other platforms

Libre by Abbott (v1.2.0)

590,586 4.28

(29,224)

For Developers

Monetize with App Pass Boost with Extension Booster

Contact the developer

Chrome-Stats does not own this Apple app. Please use these information below to contact the Apple app developer.

Developed by:

Abbott Labs

Apple Apps Store

https://apps.apple.com/us/app/libre-by-abbott/id6670330506

User Reviews

This is actually demonstrating when my blood sugar is crashing. And the sensor is smaller than previous version. Thanks for this product!

by Ar*****, 2026-06-03

Wakes me up early with alarm saying my levels are low but after a few minutes it registers normal after me doing nothing Does not match when I finger poke

by Co*****, 2026-06-03

I have been using a Libre 3 for a couple of years and I think the device is a lifesaver if only the app was more reliable! I have signal loss every day. I do like that my doctors have access to all my data and able to adjust my insulin as needed. Overall, I think this is an asset for diabetics but with technology so advanced, I think there would be a solution to the signal loss problem.